SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-217507
Filing Date
2019-08-09
Accepted
2019-08-09 08:16:04
Documents
3
Period of Report
2019-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d791182d8k.htm 8-K 17197
2 EX-99.1 d791182dex991.htm EX-99.1 79948
3 GRAPHIC g791182dsp4.jpg GRAPHIC 10738
  Complete submission text file 0001193125-19-217507.txt   113167
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38079 | Film No.: 191011391
SIC: 2834 Pharmaceutical Preparations